tradingkey.logo
tradingkey.logo
Search

Artelo Biosciences Inc

ARTL
Add to Watchlist
3.940USD
-0.030-0.76%
Close 09-18 16:00ET
1.85MMarket Cap
LossP/E TTM

ARTL Financials

See Artelo Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.85M
Dividend TTM
0.00
P/E TTM
-0.14
EPS TTM
-28.54
Revenue
--
Net Profit
-9.83M
ROE
-367.70%
ROA
-167.97%

Artelo Biosciences Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
52.16%-8.05
69.24%-4.00
70.43%-6.18
-88.42%-11.89
-24.08%-16.83
6.92%-13.01
-20.14%-20.91
-26.68%-6.31
-303.87%-13.57
-206.94%-13.98
-146.05%-17.40
---4.98
---3.36
---4.55
---7.07
---2.38
----
----
----
----
Net Profit
24.65%-2.43M
-24.70%-2.96M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.60M
-10.33%-2.17M
-76.98%-3.34M
-3.57%-2.33M
-31.25%-2.45M
-36.97%-1.96M
-83.67%-1.89M
-136.52%-2.25M
Debt to assets ratio
-100.00%0.00%
--5.27%
--21.74%
--20.51%
--18.15%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
20.48%-2.50M
-13.03%-2.69M
26.92%-2.79M
-158.49%-3.09M
-25.40%-3.15M
8.11%-2.38M
-17.65%-3.81M
54.28%-1.20M
-40.81%-2.51M
-12.96%-2.59M
6.79%-3.24M
-9.19%-2.61M
27.80%-1.78M
-17.78%-2.29M
-84.22%-3.48M
-6.33%-2.39M
-32.32%-2.47M
-35.59%-1.95M
-83.65%-1.89M
-136.64%-2.25M
Net Profit
24.65%-2.43M
-24.70%-2.96M
-10.27%-4.17M
-175.62%-3.12M
-32.39%-3.22M
4.47%-2.37M
-22.94%-3.78M
53.78%-1.13M
-52.16%-2.43M
-14.53%-2.48M
7.97%-3.07M
-5.11%-2.45M
34.71%-1.60M
-10.33%-2.17M
-76.98%-3.34M
-3.57%-2.33M
-31.25%-2.45M
-36.97%-1.96M
-83.67%-1.89M
-136.52%-2.25M
Current assets
95.75%4.37M
654.05%10.42M
-72.82%695.00K
-63.36%1.83M
-63.80%2.23M
-83.12%1.38M
-76.71%2.56M
-62.87%4.99M
-57.76%6.17M
-50.03%8.19M
-40.07%10.98M
-33.86%13.43M
-34.47%14.60M
-33.36%16.39M
77.59%18.32M
97.11%20.30M
95.37%22.28M
227.86%24.59M
341.43%10.32M
609.08%10.30M
Total current liabilities
-74.53%1.46M
107.85%5.83M
128.22%4.04M
597.27%4.86M
507.66%5.71M
288.90%2.80M
37.26%1.77M
-24.32%697.00K
55.89%940.00K
-12.61%721.00K
29.36%1.29M
91.88%921.00K
14.42%603.00K
-5.71%825.00K
89.73%998.00K
13.22%480.00K
-10.52%527.00K
80.18%875.00K
4.74%526.00K
57.92%423.94K
Total assets
48.24%6.46M
256.13%12.52M
-40.38%2.80M
-40.20%4.27M
-47.67%4.36M
-66.05%3.52M
-63.98%4.70M
-53.96%7.14M
-50.67%8.33M
-43.97%10.35M
-36.14%13.04M
-30.85%15.50M
-30.85%16.88M
-30.80%18.48M
61.65%20.42M
81.65%22.41M
81.52%24.41M
179.94%26.70M
188.68%12.63M
253.22%12.34M
Total liabilities
-74.63%1.46M
104.19%5.85M
121.24%4.07M
532.26%4.90M
461.15%5.76M
250.43%2.86M
42.60%1.84M
-15.85%775.00K
68.64%1.03M
-2.74%817.00K
26.44%1.29M
79.88%921.00K
7.41%609.00K
-9.09%840.00K
72.18%1.02M
20.77%512.00K
-3.73%567.00K
90.27%924.00K
18.09%593.00K
57.92%423.94K
Total equity
455.41%5.00M
923.31%6.67M
-144.52%-1.27M
-109.95%-633.00K
-119.26%-1.41M
-93.16%652.00K
-75.69%2.86M
-56.37%6.36M
-55.13%7.30M
-45.93%9.54M
-39.43%11.75M
-33.44%14.58M
-31.76%16.27M
-31.58%17.64M
61.13%19.40M
83.81%21.90M
85.43%23.84M
184.74%25.78M
210.79%12.04M
269.47%11.92M
Net operating income
-879.18%-5.03M
25.42%-1.19M
-13.40%-2.91M
-349.61%-3.50M
75.08%-514.00K
45.72%-1.60M
1.12%-2.57M
56.83%-778.00K
-27.11%-2.06M
-34.58%-2.94M
-13.21%-2.60M
-6.25%-1.80M
17.45%-1.62M
-6.48%-2.19M
-48.77%-2.29M
4.75%-1.70M
-31.06%-1.97M
-55.64%-2.05M
-76.61%-1.54M
-74.47%-1.78M
Net investment
----
----
-62.40%188.00K
-105.88%-250.00K
-100.00%0.00
-100.00%0.00
-81.76%500.00K
331.99%4.25M
338.60%1.75M
-42.29%1.27M
52.62%2.74M
40.52%-1.83M
-89.99%399.00K
755.64%2.20M
152.22%1.80M
-703.10%-3.08M
880.31%3.98M
--257.00K
-292531.97%-3.44M
--510.69K
Net financing
-158.59%-1.06M
--10.86M
2719.30%1.61M
--3.44M
--1.82M
-100.00%0.00
78.13%57.00K
-100.00%0.00
--0.00
--55.00K
-76.12%32.00K
--535.00K
----
----
-91.61%134.00K
-100.00%0.00
-102.52%-134.00K
-100.00%0.00
-6.62%1.60M
118.45%617.48K

FAQs

What are the current assets of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its current assets were 695.00K, with a year-on-year change of -72.82.

What are the total assets of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its total assets of Artelo Biosciences Inc were 2.80M, with a year-on-year change of -40.38.

What are the total liabilities of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its total liabilities of Artelo Biosciences Inc were 4.07M, with a year-on-year change of 121.24.

What is the total equity of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its total equity of Artelo Biosciences Inc was -1.27M, with a year-on-year change of -144.52.

What is the net operating income of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its net operating income of Artelo Biosciences Inc was -11.40M, with a year-on-year change of -12.82.

What is the net investment of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its net investment of Artelo Biosciences Inc was -62.00K, with a year-on-year change of -100.80.

What is the net financing of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its net financing of Artelo Biosciences Inc was 6.87M, with a year-on-year change of 6031.25.

What is the Earnings Per Share (EPS) of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -337.93, with a year-on-year change of -515.80.

What is the net income of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its net income was -12.88M, with a year-on-year change of -31.07.

What is the Return on Equity (ROE) of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -1625.11, with a year-on-year change of -1108.08.

What is the Return on Assets (ROA) of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -343.49, with a year-on-year change of -210.08.

What is the operating profit of Artelo Biosciences Inc?

According to Artelo Biosciences Inc's FY2025 earnings report, its operating profit was -11.40M, with a year-on-year change of -12.82.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.